Glenmark Pharma is down in the red today morning; going down to Rs.671.20. Its 52-week low is at Rs.600.

The market is anxious about the news that its Aurangabad plant is getting ready for inspection by the US FDA by next week.

This plant is mainly of API and formulations. It was last inspected in 2015 by the FDA.

Any news to do with the FDA is a big worry despite the fact that the contribution of this unit is small.